ASTRAZEN.NS(ASTRAZEN.NS)
ASTRAZEN.NS
No analyst ratings available
No analyst price targets available for ASTRAZEN.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $8.38B | $8.38B | $9.07B | $10.06B |
| Low | $8.38B | $8.38B | $9.07B | $10.06B |
| High | $8.38B | $8.38B | $9.07B | $10.06B |
| EBITDA Avg | $1.17B | $1.17B | $1.27B | $1.41B |
| Low | $1.17B | $1.17B | $1.27B | $1.41B |
| High | $1.17B | $1.17B | $1.27B | $1.41B |
| EBIT Avg | $1.03B | $1.03B | $1.11B | $1.24B |
| Low | $1.03B | $1.03B | $1.11B | $1.24B |
| High | $1.03B | $1.03B | $1.11B | $1.24B |
| Net Income Avg | $833M | $833M | $808M | $913M |
| Low | $833M | $833M | $808M | $913M |
| High | $833M | $833M | $808M | $913M |
| EPS Avg | $33.34 | $33.34 | $32.31 | $36.51 |
| Low | $33.34 | $33.34 | $32.31 | $36.51 |
| High | $33.34 | $33.34 | $32.31 | $36.51 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |